In this study, we quantitatively determined the methylation levels of F2RL3 in the blood DNA of the 180 CHD patients and 184 controls using Agena MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometry. The gene discussed is F2RL3; the disease is coronary artery disorder.